Infectious Disease

Top Story

Gilead announces continued focus on HBV, HCV, NASH

July 26, 2017

During an earnings conference call today, executives from Gilead Sciences disclosed second quarter earnings and projected pipeline goals with a focus on the company’s hepatitis B, hepatitis C and nonalcoholic steatohepatitis treatments.

Product sales for HIV and HBV as a combined market were $3.6 billion in the second quarter of 2017, compared with $3.1 in the same quarter of 2016. According to Robin Washington, company executive vice president and chief financial officer, the increase was primarily due to continued uptake of the company’s Vemlidy (tenofovir alafenamide)-based products. Overall sales increased 11% from the previous quarter.

In the Journals

HIV infection associated with subsequent squamous cell carcinoma risk

July 26, 2017
Non-Hispanic white patients with HIV and a history of nonmelanoma skin cancer had a higher risk for subsequent new primary squamous cell carcinoma, which was…

‘Unprecedented’ dengue outbreak in Sri Lanka exceeds 107,000 cases

July 26, 2017
The Epidemiology Unit of Sri Lanka’s ministry of health has been notified of 107,015 suspected cases of dengue fever since January, which WHO estimates is a…
FDA News

FDA approves new rapid C. diff test

July 26, 2017
Luminex announced that the FDA has cleared its Aries C. difficile assay for rapid detection of the infection. The real-time polymerase chain reaction (PCR)-based…

IDSA, AASLD critical of Cochrane review of HCV drugs

July 26, 2017
Members of the Infectious Diseases Society of America and the American Association for the Study of Liver Diseases have issued a strongly worded rebuke of a recent…
More Headlines »
CME

The Patient with Otitis Media

No commercial support for this activity.

Acute otitis media (AOM), a common disease of childhood, is diagnosed by careful otoscopy with an understanding of…
More »

‘Unprecedented’ dengue outbreak in Sri Lanka exceeds 107,000 cases

July 26, 2017
The Epidemiology Unit of Sri Lanka’s ministry of health has been notified of 107,015 suspected cases of dengue…
More »
Resource Centers
ASM Microbe

ASM Microbe

Video
Meeting News

VIDEO: Vaccine significantly reduces risk for influenza-related death in children

June 5, 2017
More »
Advertisement
Advertisement